Stroke is the leading cause of death in China. Despite the wide dissemination of evidence-based guidelines, data about adherence to these in routine clinical practice are scarce. We conducted a study using a nationwide registry to evaluate the implementation of evidence-based stroke performance indicators and associated guidelines, for patients with an ischemic stroke in China.
S
troke is a leading cause of death worldwide, 1 imposing enormous burden on nations with diverse healthcare systems. 2 Despite the wide dissemination of evidence-based guidelines for the prevention and treatment of stroke, many patients do not receive these recommended interventions. [3] [4] [5] [6] [7] In China, stroke is the leading cause of death and acquired disability in adults. 8, 9 Currently, >7 million Chinese people have a history of stroke, with 2 million new and recurrent strokes diagnosed each year. 9 Thus, there is an urgent need to improve stroke care and its outcomes in China. 10, 11 The China National Stroke Registry (CNSR) 12 was planned to assess stroke care in China. The registry and other studies have revealed that adherence to the evidence-based guidelines has not been systematically evaluated in clinical practice. 13, 14 Improving the quality of stroke care has become a global priority. [15] [16] [17] [18] [19] [20] The American Heart Association/ American Stroke Association Get With The GuidelinesStroke (GWTG-Stroke) program is a US-based stroke quality measurement and improvement program and represents the world's largest stroke registry. The GWTG-Stroke program has shown a substantial and sustained improvement in stroke care. 15, 20, 21 A recent study in Taiwan has demonstrated that hospital adherence with GWTG-Stroke guideline indicators was associated with improved patient outcomes, based on a subset of GWTG-Stroke performance measures. 17 We conducted this study to assess the quality of stroke care in China based on the 9 performance measures adopted by the GWTG-Stroke program and 3 additional indicators recommended by the national stroke guidelines for China. 14 We explored the patient and hospital characteristics that independently predicted the composite score of these performance measures in a Chinese patient population with ischemic stroke (IS). We also examined whether use of more evidence-based care processes was associated with better outcomes. This would support the generalization of lessons from the GWTG-Stroke program to a population with very different demographics, risk factors, disease burden, 2 health economics, and healthcare delivery system. 22 
METHODS

CNSR Design
CNSR is a national hospital-based, prospective cohort study sponsored by the Ministry of Health. The primary objective of the registry is to evaluate the quality of care provided during acute hospitalization, for all stroke patients. The design of CNSR has been described previously. 12 Patients were eligible if they were ≥18 years of age and presented within 14 days of the onset of symptoms, and the diagnosis was confirmed by brain computed tomography or magnetic resonance imaging. Trained research coordinators at each hospital reviewed the medical records daily to identify, obtain consent, and enroll the patients consecutively. The study was approved by the Central Institutional Review Board at Beijing TianTan Hospital. Written informed consent was obtained from the patient or his/her legal representative as required by the national guidelines.
Site Selection
In China, hospitals are classified into 3 grades: community hospitals serving just 1 community are defined as grade I, hospitals that serve several communities are defined as grade II, and central hospitals for a certain district or city are defined as grade III or tertiary hospitals and are usually teaching hospitals. 23 In CNSR, 132 hospitals representing 27 provinces and 4 municipalities (except for Taiwan and Macao regions) in China were selected by the CNSR steering committee. Among them, 100 were tertiary hospitals and 32 were grade II hospitals. Two principles were followed for the assessment and screening: first, ensuring representation from each of the 27 provinces and 4 municipalities in Mainland China; and second, ensuring representation of hospital levels, that is, the selected sites should not only cover academic and tertiary hospitals but also include secondary and primary hospitals. However, because of low anticipated volumes and a lack of research resources for the study, the CNSR did not include primary hospitals. All selected sites were voluntary, and none were involved in quality improvement programs.
Data Collection
According to the annual report on health statistics of China, 24 the hospitals are divided into 3 regions: Eastern, Central, and Western. Other hospital-level characteristics included the
WHAT IS KNOWN
• In China, the leading cause of death is stroke (1.7 million deaths). Currently, more than seven million Chinese people suffer from stroke and about two million Chinese people have a new or recurrent stroke each year.
• Improving stroke care quality has become a global priority. Get With The Guidelines-Stroke, the world's largest stroke registry, has demonstrated substantial and sustained improvement in stroke care.
• The China National Stroke Registry was initiated to assess the quality of stroke care in China.
WHAT THE STUDY ADDS
• In the largest registry of acute stroke care among patients hospitalized with acute ischemic stroke in China, there were still significant gaps, variations, and disparities between guideline-based recommendations and clinical practice in the management of acute ischemic stroke.
• This study demonstrates that adherence to select ischemic stroke performance measures was associated with better clinical or/and functional outcomes with various strength of association.
total bed size, academic or nonacademic status, annual volume of stroke discharges, and stroke unit. Academic status was defined as hospitals affiliated to some university. Stroke units were defined as areas in a hospital where physicians, nurses, and other ancillary staff had training and experience in stroke management and provided care for patients of acute stroke. A standardized data collection form was used by all the sites. Trained research coordinators obtained the following data directly, by interviewing the patients and their families about the time of symptom onset (defined as the time when stroke-related symptoms first occurred or the patient was last known to be well), prehospital care, prestroke modified Rankin Scale, 22 and baseline Glasgow Coma Scale, 25 and National Institutes of Health Stroke Scale 26, 27 for all enrolled patients. Other data extracted from the medical records included the patient demographics, medical history, medication use, stroke subtypes, disease status, neuroimaging findings, complications during hospitalization, disease management in different hospital settings, and discharge status. The vascular risk factors considered included history of stroke (defined as a history of stroke, including IS, intracerebral hemorrhage, or subarachnoid hemorrhage confirmed on medical records), hypertension (resting blood pressure ≥140/90 mm Hg on repeated measurements during hospitalization or ongoing antihypertensive medication), dyslipidemia (total cholesterol ≥240 mg/dL, high-density lipoprotein <35 mg/dL, LDL [low-density lipoprotein] ≥160 mg/dL, or use of lipid-lowering agents), atrial fibrillation (a reported history of atrial fibrillation, or diagnosed from the patient's in-hospital ECG), coronary heart disease (a reported history of myocardial infarction or cardiac surgery, or with a final diagnosis of myocardial infarction at discharge), peripheral artery disease (a reported history of peripheral artery disease, or diagnosed using the patient's in-hospital vascular ultrasound), diabetes mellitus (DM; self-reported physician diagnosis of DM, hypoglycemic medications, eg, insulin or sulfonylureas before and during hospitalization, or with a final diagnosis of DM at discharge), and current or previous history of smoking, moderate or heavy alcohol consumption (≥2 standard alcohol consumption per day). Patients were contacted by telephone at 3, 6, and 12 months after discharge by trained research personnel who followed standardized scripts to collect information on the functional status and clinical outcomes. During the follow-up periods, stroke recurrences associated with rehospitalization were confirmed by contacting the hospitals where the patients were readmitted to ensure reliable diagnosis. These events were attributed to the index hospital where the first stroke was treated. In case of a suspected recurrent cerebrovascular event without hospitalization, the judgment was made by the research coordinators together with the principle investigator (Y.W.). Each death was either confirmed by the death certificate from the local citizen registry or from the medical records. In cases lacking local citizen registry information or death without hospitalization, case fatality was deemed reliable if death was reported on 2 consecutive follow-up periods by different proxies.
Copies of the medical charts of 30 patients (3 from each of the 10 randomly selected hospitals) were selected (limited by the centralized training period and resources) with their patient-identifiable information removed. Trained research coordinators retrieved the data from these charts, using standardized data collection forms. Twenty randomly selected nominal variables were used to estimate the interrater agreement for the data collection, which was assessed using the overall percentage of agreement 28 and the κ statistic. Summary κ scores and percentage agreement were calculated for each variable. The overall κ score was calculated by summation of the score for each variable. 29 The overall interrater agreement for the data collected was consistent, with an overall κ value of 0.71 (95% CI, 0.63-0.79).
All data elements were manually audited by a research specialist from an independent research organization, Giant Med-Pharma Services, Inc. A professional data processing company entered the data. Beijing Translational Medicine Research Center, an independent research organization, analyzed the data.
Performance Measures for Stroke Care and Prevention
Nine performance measures adapted from the GWTGStroke 20 and 3 guideline-related additional indicators were selected by the CNSR Steering Committee to measure the quality of inpatient stroke care based on a combination of strength of evidence, clinical significance, precision of the definition, content validity, and feasibility of implementation in clinical practice.
The 9 GWTG-Stroke performance indicators included were as follows: (1) administration of intravenous tPA (tissuetype plasminogen activator) in patients who arrived within 2 hours after onset of symptoms and treated within 3 hours; in-hospital measures including (2) antithrombotic medication within 48 hours of admission, (3) deep vein thrombosis prophylaxis within 48 hours of admission for nonambulatory patients, and discharge measures including (4) antithrombotic medication, (5) anticoagulants for atrial fibrillation, (6) medication for lowering LDL if LDL ≥100 mg/dL, 30 or patients treated with lipid-lowering agents before admission, or LDL not documented, (7) counseling or medication for smoking cessation, (8) dysphagia screening before feeding, and (9) stroke education. Apart from these 9 indicators based on the GWTG-Stroke guidelines, the following 3 performance indicators were also included: carotid imaging for patients with acute IS as an in-hospital measure, hypoglycemic medication for DM at discharge, and antihypertensive medication for hypertension as discharge measures.
All measures reflect the proportion of eligible patients who received the intervention as described. In-hospital measures, except for intravenous tPA administration within 2 hours after onset of symptoms, excluded patients who died within 48 hours after admission, and discharge measures excluded patients who died in hospitals or in whom the discharge status was blank or could not be determined. The primary outcome was the optimal compliance with intravenous tPA, in-hospital management, discharge management, and overall measures. In addition, the in-hospital composite measure, discharge composite measure, and overall composite measure which are similar to the ones reported by GWTG-Stroke 15, 20 were also calculated. These measures reflect the summary scores of the corresponding 4 in-hospital, 7 discharge, and all 12 individual performance measures, respectively. A composite measure was defined as the total number of interventions performed among recruited patients divided by the total number of possible interventions among the recruited patients. The optimal compliance measures were defined as the proportion of patients who received all of the performance measure interventions for which they were eligible. 15 
Patient Outcomes Assessment
The secondary study outcomes were patients' clinical and functional status including stroke recurrence, 1-year favorable functional outcome (defined as modified Rankin Scale score of ≤2), 1-year death after stroke onset reflecting timely use of intravenous tPA, 1-year death 48 hours post-admission reflecting in-hospital performance measures, and 1-year postdischarge death reflecting discharge performance measures. Death after stroke referred to death occurring after the onset of initial stroke symptoms. Death 48 hours post-admission referred to death occurring 48 hours after patients were admitted. Post-discharge death referred to death after discharge from hospital.
Statistical Analysis
We reported patient and hospital characteristics, medical history, presenting disease status for the overall cohort and for patients with follow-ups. Proportions were used for categorical variables, and medians with interquartile range were used for nominal variables. The median of hospital-level compliance rate along with the 10th to 90th percentiles weighted by the number of patients in each hospital for each individual measure and the composite measure were calculated. We used multivariable logistic regression with generalized estimating equations to examine the patient and hospital characteristics associated with intravenous tPA use, and with optimal compliance to the 4 in-hospital, 7 discharge, and all the 12 performance measures. Patients were considered clustered within the index hospital in the models.
Multivariable Cox regression models were used to examine the association (1) between the clinical and functional outcomes and intravenous tPA use among all study patients, (2) between the outcomes and optimal in-hospital performance among patients who survived 48 hours after admission, and (3) between the outcomes and optimal discharge performance among patients who survived until discharge. For intravenous tPA usage, in-hospital, and discharge measures, the follow-up period started after 6 hours of admission, 48 hours of admission, and time at discharge, respectively. In addition, we also examined the association between performance measures with clinical and functional outcomes using multivariable Cox proportion hazard model. All models were adjusted for age, sex, body mass index, National Institutes of Health Stroke Scale at admission, Glasgow Coma Scale at admission, education level, health insurance cover, prestroke modified Rankin score, history of prior stroke, DM, hypertension, atrial fibrillation or flutter, coronary artery diseases, medical complication after admission including epileptic seizure, hydrocephalous, pulmonary embolism, deep vein thrombosis, gastrointestinal bleeding, urinary tract infection and pneumonia, 31 family income (monthly income ≤1000 Chinese yuan or above), and marital status. Patients were censored to loss of follow-up and death.
All P are 2-sided, with values of P<0.05 considered statistically significant. All statistical analyses were performed using SAS Version 9.1 software (SAS Institute, Cary, NC).
RESULTS
Patient demographics, vascular risk factors, and hospital characteristics for the overall and analysis cohorts are shown in Table 1 . Overall, 12 416 patients with at least 1 follow-up were included in this study, of which 12 329 (99.3%) survived at least 48 hours after admission and 11 919 (96.0%) survived until discharge. The median follow-up duration was 327 days. In the study cohort, the median age of the patients was 67 years (interquartile range, 57-75 years) and female patients accounted for 38.3% of all patients. Only 50.9% of the patients availed of emergency medical services after the onset of stroke, and the median time from the onset of symptoms to arrival at hospital was 24.7 hours (interquartile range, 7.2-64.3 hours). Patients (63.3%) were from the eastern regions of China, and 34.1% of the patients had a history of previous stroke or transient ischemic attack.
The median rate of hospital adherence to performance measures in acute stroke care and prevention are shown in Table 2 . Of the 12 416 patients included in the study, 1368 (11.0%) arrived within 2 hours of stroke onset and 1203 of them were eligible for intravenous tPA. However, only 170 (6.5%) IS patients received intravenous tPA within 3 hours, and 24.1% of the patients with atrial fibrillation received anticoagulation treatment at discharge. The best performance was for the use of acute antithrombotics (81.8%) and counseling for cessation of smoking (69.8%). For the 3 additional performance measures, 64.1% of patients with acute IS were sent for a carotid imaging, 58.2% of hypertensive patients were treated with antihypertension medications, and 66.7% of patients with DM were treated with antidiabetic medications at discharge. The composite measure, a summary score of all 12 individual performance measures, was 61.2%, and the corresponding optimal compliance was 0.3%. Multivariable logistic analysis with generalized estimating equations estimates showed that patients with lower National Institutes of Health Stroke Scale score at admission were more likely to receive intravenous tPA and optimal care, which was in compliance with in-hospital measures, discharge measures, and all measures combined (Table 3) . Patients admitted to the teaching hospitals or from more developed regions had higher odds of receiving intravenous tPA, overall optimal compliance, and in-hospital optimal compliance. Patients admitted to a hospital having a stroke unit facility had higher odds of receiving overall optimal compliance in-hospital and discharge optimal compliance. The multivariable-adjusted estimates between tPA use, optimal compliance with in-hospital and discharge measures, and the 1-year outcomes are shown in Table 4 . The optimal compliance with in-hospital measures was associated with a reduced rate of 1-year death, 48 hours after admission (hazard ratio, 0.66; 95% CI, 0.55-0.79). Optimal compliance with discharge measures was associated with reduced 1-year death rate after discharge (hazard ratio, 0.55; 95% CI, 0.44-0.69), 1-year stroke recurrence rate (hazard ratio, 0.81; 95% CI, 0.70-0.93), and with favorable functional outcomes (hazard ratio, 1.10; 95% CI, 1.04-1.16).
DISCUSSION
This study aimed to assess the care provided for patients with acute IS admitted to hospitals in China and to investigate the association of stroke care with patient outcomes. Using a standard set of performance measures, we found significant gaps in the quality of care provided in China for acute IS. Our study showed that, even in a very different system of care, adherence to standard IS performance measures was independently associated with better clinical and functional outcomes.
Some areas of stroke care quality were still poor in China, especially with respect to intravenous tPA use, use of anticoagulants for atrial fibrillation, and use of lipid-lowering agents for patients with LDL ≥100 mg/dL. These gaps might widen further because the quality of stroke care in the developed regions/countries has been rapidly improving with proactive performance improvement interventions. 15, 16, [18] [19] [20] Although intravenous tPA for acute stroke is strongly recommended, 5 the rate of intravenous tPA administration among enrolled patients in our study was low. The number of patients who were candidates for intravenous tPA was 1203 out of 12 415, thus limiting the power to detect the association of intravenous tPA use with patients outcomes. The barriers in administering intravenous tPA include prehospital or in-hospital delay, short treatment time window, and lack of hospital infrastructure and readiness. 32 In our study, the rate of adherence to intravenous tPA usage was varied and suboptimal.
Recent studies have also demonstrated that adherence to GWTG-Stroke guideline indicators 17 and other processes of care 33 were associated with improved outcomes of acute stroke. We also observed that the compliance of all 4 in-hospital performance measures BMI indicates body mass index; CNY, Chinese Yuan (≈7.3 CNY was equivalent to $1 USD); GCS, Glasgow Coma Scale; GRPPC, Gross regional product per capita; IQR, interquartile range; IV tPA, intravenous tissue-type plasminogen activator; and NIHSS, National Institutes of Health Stroke Scale. was associated with reduced mortality after admission, which supports the need for improvement in acute inhospital interventions. In our study, the rate of optimal compliance with the 4 in-hospital measures was very low, which calls for an urgent improvement in the early management of patients with IS in China.
Control of vascular risk factors is important to reduce the risk of recurrent stroke. 7 Our study also found that optimal compliance to the secondary prevention measures at discharge was associated with a reduced rate of mortality or stroke recurrence. However, the rate of optimal compliance the discharge measures was also suboptimal.
For patients with IS, the use of antithrombotics at admission or discharge is strongly recommended to reduce the risk of recurrence. 7 However, only about 70% of eligible patients received antithrombotics during hospitalization or at discharge, and less than onequarter of patients with atrial fibrillation received anticoagulants at discharge. For stroke patients with atrial fibrillation, only large tertiary hospitals have the facility to monitor international normalized ratio. Many physi- Additional variables adjusted in the models included age, sex, body mass index, education, prestroke modified Rankin score, admission Glasgow Coma Scale, history of prior stroke, diabetes mellitus, hypertension, atrial fibrillation or flutter, coronary artery diseases, medical complication after admission including epileptic seizure, hydrocephalous, pulmonary embolism, deep vein thrombosis, gastrointestinal bleeding, urinary tract infection and pneumonia, family income (monthly income ≤1000 rmb or above), and marital status. aRR indicates adjusted rate ratio; CNSR, China National Stroke Registry; CNY, Chinese Yuan; GEE, generalized estimating equations; GRPPC, gross regional product per capita; IV tPA, intravenous tissue-type plasminogen activator; and NIHSS, National Institutes of Health Stroke Scale.
cians, especially in the lower level hospitals, therefore, are reluctant to prescribe warfarin. This might be 1 reason for the poor use of anticoagulants in CNSR.
The usage of lipid-lowering therapies was considerably low (37.4%), which is consistent with findings about the use of secondary prevention methods for IS in China. 34 Statin treatment is yet relatively expensive in China and only partly covered by insurance.
Recent data indicate that DM has emerged as a major public health problem, 35 which independently predicts poor outcomes for patients with acute IS in China. 36 Only 66.0% of eligible patients, however, received antidiabetic therapy in this study. Hypertension is the most important risk factor for stroke in China. 37 It is estimated that >177 million adults are hypertensive in China. 38 CNSR therefore included antihypertensive therapy at hospital discharge as a performance measure. The relatively low rate of compliance to this preventive measure in CNSR indicates a large opportunity to improve the quality of hypertension management for patients with IS in China.
Currently, there are >300 million smokers in China. 38 Counseling for smoking cessation was provided to 69.6% of smokers in the CNSR. Limited by the funding, we were not able to obtain the information on who actually complied and stopped smoking. Smoking cessation education/treatment needs to be further strengthened in China. Overall, optimal compliance to the in-hospital and discharge measures was associated with better clinical and functional outcomes. Our study supported the findings reported by others. 17, 33, 39 There are several potential reasons for the association between performance measure adherence and outcomes. Currently, about 57% of the Chinese population lives in rural areas, but 80% of the hospitals are urban. 40 More resources, modern technology, and better care are mainly concentrated in large city hospitals. 24 Patients with better performance measures might have been those admitted to hospitals with high quality of stroke care and might have received better additional in-hospital treatment, besides the recommended therapies. Improving the quality of stroke care has become a national priority in China. 41 A targeted multifaceted intervention including a clinical pathway, care protocols, quality supervising, and performance measure monitoring and feedback has bridged the evidence-based gap in the management of acute IS in China. 42 Moreover, patients who did well in 1 performance measure might have also received other recommended therapies. Third, patients who received more of the recommended therapies might be more likely to adhere to the recommended medications than patients who received fewer of the recommended therapies. In addition, because this is an observational study, even after adjustment for confounding factors, we cannot be certain that differences in the underlying prognosis contributed to the differences in outcomes between patients who did and did not receive the recommended interventions. Therefore, interpretation of these associations needs to be very careful.
There were several limitations in our study. First, the participating hospitals were selected by convenience. Majority of the hospitals selected were tertiary hospitals and might not represent the quality of care in the rural and smaller community hospitals. It is not known what proportion of stroke patients in China currently have access to similar levels of care as that available in the hospitals that participated in our study. Second, the data were collected based on the No documentation, means Not done assumption. Some data (such as swallow assessment on admission) might not always be reported in the medical records though it might have been performed at the bedside. Some patients might have had contraindications that were not documented. Therefore, the adherence to some performance indicators in practice might be underestimated. Third, we randomly audited only a small number of medical records. A more comprehensive audit might have identified greater data collection inaccuracies. Fourth, patients who were lost to follow-up were excluded in this analysis. These patients might have had different Favorable functional outcome was defined as modified Rankin Scale score of ≤2 and assessed at 1 y after stroke onset. Models were adjusted for age, sex, body mass index, admission National Institutes of Health Stroke Scale, admission Glasgow Coma Scale, education, health insurance, prestroke modified Rankin score, history of prior stroke, diabetes mellitus, hypertension, atrial fibrillation or flutter, coronary artery diseases, medical complication after admission including epileptic seizure, hydrocephalous, pulmonary embolism, deep vein thrombosis, gastrointestinal bleeding, urinary tract infection and pneumonia, family income (monthly income ≤1000 rmb or above), and marital status. HR indicates hazard ratio; and IV tPA, intravenous tissue-type plasminogen activator.
*Death: death after stroke onset for tPA usage, death 48 h post-admission for in-hospital measure, death after discharge for discharge measure.
socioeconomic characteristics or might have received poorer quality of care than those included in the study. Excluding them might have affected the relationship between the adherence to performance measures and outcomes. Last, accessibility and feasibility of rehabilitation assessment for stroke patients varies widely in different hospitals and regions in China. Because the rehabilitation type and duration were not documented in the CNSR, we were unable to adjust for these factors when evaluating the association between the performance measures and outcomes in our analysis. In addition, some (if not all) of these performance indicators might be related and a high-performing hospital was more likely to have adopted many of these processes. Adjustment for hospital characteristics might not be able to remove this confounding factor completely.
CONCLUSIONS
In the largest study till date about the care provided to patients hospitalized with acute IS in China, adherence to tPA usage and 2 optimal compliance in-hospital and discharge measures was associated with better clinical and functional outcomes with various strengths of association. This study also suggested that there are substantial opportunities for improvement in the quality of stroke care in China. Because this was an observational study, the results should be interpreted with caution. More comparative studies are needed in the Chinese stroke patients' population.
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